130 related articles for article (PubMed ID: 36441107)
41. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].
Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823
[TBL] [Abstract][Full Text] [Related]
42. Molecular Mechanisms and Therapies of Myeloid Leukaemia.
Brown E; Guinn BA
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682932
[TBL] [Abstract][Full Text] [Related]
43. Cellular dysmaturity as a prognostic index in acute myeloid leukaemia.
O'Connell LG; Gorman A; Keane TJ; Fennelly JJ
Ir J Med Sci; 1976 Feb; 145(2):35-43. PubMed ID: 1063114
[No Abstract] [Full Text] [Related]
44. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
45. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
46. Small bone marrow adipocytes predict poor prognosis in acute myeloid leukemia.
Lu W; Weng W; Zhu Q; Zhai Y; Wan Y; Liu H; Yang S; Yu Y; Wei Y; Shi J
Haematologica; 2018 Jan; 103(1):e21-e24. PubMed ID: 29051282
[No Abstract] [Full Text] [Related]
47. Aleukaemic leukaemia cutis: case report and review of the literature.
Wilkins R; Janes S
Clin Lab Haematol; 2004 Feb; 26(1):73-5. PubMed ID: 14738442
[TBL] [Abstract][Full Text] [Related]
48. Percentage of S-phase cells in bone marrow aspirates, biopsy specimens and bone marrow aspirates corrected for blood dilution from patients with acute leukemia.
Colly LP; Peters WG; Hermans J; Arentsen-Honders W; Willemze R
Leuk Res; 1987; 11(3):209-13. PubMed ID: 3470574
[TBL] [Abstract][Full Text] [Related]
49. Treating second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia: Successful salvage rather than palliation?
Merli P
Br J Haematol; 2022 Jun; 197(6):651-652. PubMed ID: 35435248
[TBL] [Abstract][Full Text] [Related]
50. The serial study of c-myc expression in bone marrow biopsy specimens during treatment for acute myelogenous leukaemia.
Banavali SD; Pancoast JR; Tricot G; Larson R; Goldberg J; Raza A; Bismayer JA; Preisler HD
Eur J Cancer; 1993; 29A(8):1162-7. PubMed ID: 8518028
[TBL] [Abstract][Full Text] [Related]
51. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
[TBL] [Abstract][Full Text] [Related]
52. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
53. LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
Patel JL; Pournazari P; Haggstrom SJ; Kosari F; Shabani-Rad MT; Natkunam Y; Mansoor A
Histopathology; 2014 Jan; 64(2):226-33. PubMed ID: 24330148
[TBL] [Abstract][Full Text] [Related]
54. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
55. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
56. Dysmegakaryopoiesis predicting response to therapy in acute myeloid leukaemia. A histologic and clinical study.
Delacrétaz F; Spertini O; Schmidt PM; Grob JP
Pathol Res Pract; 1991 Mar; 187(2-3):290-5. PubMed ID: 2068013
[TBL] [Abstract][Full Text] [Related]
57. High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow.
Weidenaar AC; ter Elst A; Koopmans-Klein G; Rosati S; den Dunnen WF; Meeuwsen-de Boer T; Kamps WA; Vellenga E; de Bont ES
Cell Oncol (Dordr); 2011 Aug; 34(4):289-96. PubMed ID: 21468688
[TBL] [Abstract][Full Text] [Related]
58. Ocular relapse in acute myeloid leukemia (M4) with normal bone marrow.
Kiratli H; Demiroğlu H; Emeç S
Int Ophthalmol; 2009 Aug; 29(4):243-5. PubMed ID: 18338107
[TBL] [Abstract][Full Text] [Related]
59. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
Becker PS
ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
[TBL] [Abstract][Full Text] [Related]
60. Day-6 bone marrow aspirate for the prediction of response to remission induction therapy for acute myelogenous leukaemia.
Peters WG; Willemze R; Zwaan FE; Colly LP
Blut; 1988 Aug; 57(2):91-5. PubMed ID: 3165680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
